Home › Osteosarcoma › New York
Osteosarcoma clinical trials in New York
11 studies for Osteosarcoma are looking for participants at sites in New York.
Cities in New York
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- New York Medical College, Valhalla
RecruitingPhase 2
Ages 12 to 39 · All sexes · Updated Sep 29, 2026 · NCT04616560Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
- Montefiore Medical Center, The Bronx
RecruitingPhase 1/2
Ages 12 to 40 · All sexes · Updated Sep 3, 2026 · NCT07725380Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Albany Medical Center, Albany
- Maimonides Medical Center, Brooklyn
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
- and 11 more
RecruitingPhase 3
Up to age 50 · All sexes · Updated Aug 25, 2026 · NCT05235165SPEARHEAD-3 Pediatric Study
- Memorial Sloan Kettering Kids, New York
RecruitingPhase 1/2
Ages 2 to 21 · All sexes · Updated Aug 11, 2026 · NCT05642455Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
- University of Rochester, Rochester
- Stony Brook University Medical Center, Stony Brook
- and 1 more
RecruitingObservational study
All ages · All sexes · Updated May 18, 2026 · NCT01790152Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
- Memorial Sloan Kettering Westchester (Consent and Followup), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- Memorial Sloan Kettering at Nassau (Consent and Followup), Uniondale
RecruitingObservational study
Ages 4 and older · All sexes · Updated Apr 17, 2026 · NCT03442465A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
- Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
- and 1 more
RecruitingPhase 2
Ages 6 to 49 · All sexes · Updated Mar 17, 2026 · NCT07477457Upfront Surgical Resection for Osteosarcoma
- Montefiore Medical Center, The Bronx
RecruitingObservational study
Ages 5 to 40 · All sexes · Updated Mar 16, 2026 · NCT06384404Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
- Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx
- New York Medical Center/ Maria Fareri Children's Hospital, Valhalla
RecruitingPhase 2
Ages 1 to 50 · All sexes · Updated Mar 13, 2026 · NCT01804634A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's Hospital at Montefiore, The Bronx
RecruitingPhase 2
18 Months – 40 Years · All sexes · Updated Aug 12, 2025 · NCT05135975From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.